Discovery Laboratories, no future here for years to come. Discovery Laboratories said July 1st that its lead drug candidate, a treatment for respiratory distress syndrome in premature infants called Surfaxin, faces “a significant hurdle for approval.” The share price plummeted over 50%
The market has a tendency to overreact to both good and bad news. So right now DSCO is looking cheap just for extremely short term day bounce. I don't see much else happening. After an FDA denial investors get scared away and product development will slowly disappear.
I was never a fan of DSCO's drug Surfaxin for infants which is used to imitate the function of the lung’s natural surfactants, fluids with a soapy consistency that reduce friction and help breathing. I think drugs for fatally sick persons are much easier to get approved in comparison to a drug for infants. The use of medication on infants to me is a delicate issue, it has little to do with science and all to do with emotion and the public's acceptance of this idea.
DSCO pipeline is not so great, almost everything in the pipeline is based around Surfaxin. I have not looked at the drugs data, but if Surfaxin does not get approved for RDS the probability of it getting approved for Bronchopulmonary Dysplasia (BPD) or Acute Respiratory Failure (ARF) go down significantly IMO. Here is a chart of DSCO's current pipeline
Since their other drugs are far from completion I would say look forward to more stock offerings and other forms of dilution. Again, no future here for years to come unless your going to be doing some day trading during these volatile time or looking for the possibility of quick short term bounce.
If your into holding stocks for years then this might be for you. If not, then there are much better picks out there.
I do not see 1.00 dollar anytime soon, which sucks since im in at .99. They would have to appeal the decision and still win the appeal. They have already said they are going to move on to their other drugs. This will take a long time.
In my opinion, I think dsco it's not a good company. I bought this 3 years ago because one of my best friends was working there one month. The problem now it's that the company doesn't have enough info to pass the aproval. And probably they will go to banktrupcy.
I got in during the earlier rejection from FDA. I went in and bought more around $1.12 range. I was plannig on taking a 50% loss when it peaked to 0.60 some time last week or two. Right at this point I am hoping some other company would come forward to support DSCO. However I have read on the net that Surfaxin may not be the right avenue for DSCO especially since 2 or 3 other of their submissions are all around Surfaxin. I am just holding at this point hoping there will be a peak back to 0.60 if not I am going to take a loss after a week or two.
I bought about $5,000 DSCO when it is @$1.03.
Now it is only about $0.36.
I hold it so far.......
What will you do now do if you were me?
When DSCO can fly up?
Thanks.......